Filter Results :

Your search for Biosimilars returned 61 reports

Sort by


Global Biosimilars And Follow-On Biologics Market Research Report 2016

21 Jun 2016  |  Published by:  9Dimen Research
2016 Global Biosimilars And Follow-On Biologics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biosimilars And Follow-On Biologics industry, focusing on the main regions (North America, Europe and Asia) and the main countries (Un...

$ 2,850.00

Read More

Large Cap Pharma US & EU Outlook 2016: Maximizing Their Strength On Fewer Therapy Class, Personalized Medicine, Novel Target And Biosimilars For Future Growth

17 Mar 2016  |  Published by:  MP Advisors
Major pharma companies are continue to improve the productivity by taking different approaches like focusing on selected therapy area and markets, merger and acquisition, divestment of non-core brands/segments and consolidation in animal health, vaccines and consumer health care business. Onco...

$ 2,000.00

Read More

Global Biologics and Biosimilars Industry Report 2016

12 Mar 2016  |  Published by:  QYResearch
The Global Biologics and Biosimilars Industry Report 2016 is a professional and in-depth study on the current state of the Biologics and Biosimilars industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structu...

$ 2,800.00

Read More

Global Oncology Biosimilars Market 2016-2020

17 Feb 2016  |  Published by:  Technavio-Infiniti Research
About Oncology BiosimilarsCancer represents a huge burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of many cancer therapeutics enables the entry of biosimilars into the market. Biosimilars are being incorporated into oncology treatment practic...

$ 3,000.00

Read More

US Biosimilars Market Opportunity & Clinical Pipeline Analysis

02 Feb 2016  |  Published by:  KuicK Research
Pharmaceutical companies benefited from the revolution in biotechnology that hit US market in 1980’s. Some of the blockbuster biologics have been introduced in market helping pharmaceutical companies to occupy major market shares. Their presence could be felt in every disease segment as they were im...

$ 2,400.00

Read More

Competitor Analysis: PTH Receptor Agonists 2016 and Teriparatide Biosimilars and Biosuperiors

01 Feb 2016  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence report titled „PTH Receptor Agonists 2016 and Teriparatide Biosimilars and Biosuperiors“ provides a competitor evaluation in the field of protein- and peptide-based agonists of the parathyroid hormone (PTH) receptor for the treatment of osteoporosis or of hypopara...

$ 220.18

Read More

Biosimilars in Oncology: Update Bulletin [Feb 2016]

01 Feb 2016  |  Published by:  FirstWord
Gain new KOL insights on the latest events that have the potential to shape the oncology biosimilars market. Topics covered include opinions about data from Sandoz’s PROTECT 1 and PROTECT 2 studies which both compared the safety and efficacy of LA-EP2006 (a proposed pegfilgrastim biosimilar) t...

$ 995.00

Read More

Human Insulin Market - Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Forecasts to 2020

04 Jan 2016  |  Published by:  MarketsandMarkets
The global human insulin market is poised to reach ~USD 39.13 billion by 2020 growing at a CAGR of 8.1% from 2015 to 2020. North America is expected to hold the largest share of the global human insulin market in 2015. Market growth of human insulin products is being propelled by growing diabetes pa...

$ 4,650.00

Read More

Biosimilars in Oncology: KOL Insight

01 Jan 2016  |  Published by:  FirstWord
Will physicians ever adopt Biosimilars in Oncology? Sceptical, survival focussed oncologists that make treatment decisions in life or death situations aren't yet ready to accept biosimilars of proven targeted treatments. So what do pharma companies need to do to increase confidence and ensu...

$ 7,900.00

Read More

Biosimilars: European Payer Perspectives (2016)

01 Jan 2016  |  Published by:  FirstWord
What’s driving the uptake of biosimilars in Europe and what still needs to be done? The European market for biosimilars has seen a year of progress and change, with more therapies available and changing attitudes from many payers. Driven by the pressing need to control drug costs, payers ha...

$ 2,195.00

Read More

Global Biosimilars Industry Report 2016

01 Dec 2015  |  Published by:  Gen Consulting Co.,Ltd.
Gen's report, 'Global Biosimilars Industry Report 2016' provides detailed market and segment level data on the Global and Chinese consumption of Biosimilars. The report provides historic, forecast and growth patterns by company, country and type/application from 2016 to 2021.This report delivers an ...

$ 2,800.00

Read More

Europe Biosimilars Market Opportunity Outlook 2020

01 Nov 2015  |  Published by:  KuicK Research
Burgeoning pressure on healthcare system has caused the regulators across the globe to look for suitable therapeutic options. Biologic drugs are commonly used for treatment of various diseases but they are costly and their alternative options are difficult to find. Biosimilars have come forth as new...

$ 2,400.00

Read More

Biosimilars: Regulatory Outlook

01 Nov 2015  |  Published by:  FirstWord
Biosimilars offer a chance to improve access to, and reduce spending on, life-saving biologic therapies. But could regulators do more to support the market? While experts believe significant regulatory progress has been made in recent years, clarity is distinctly lacking on certain issues, suc...

$ 2,195.00

Read More

World Biosimilars/Follow-on-Biologics Market - Opportunities and Forecasts, 2014 - 2020

01 Sep 2015  |  Published by:  Allied Market Research
Biosimilars or follow-on-biologics are highly similar versions of reference biologics derived from living organisms such as plants and animals. The development of biosimilars and validation with reference biologics play a significant role in the commercialization of biosimilars. Economic prici...

$ 4,515.00

Read More

Global Oncology Biosimilars Industry 2015 Market Research Report

19 Aug 2015  |  Published by:  QYResearch
The Global Oncology Biosimilars Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Oncology Biosimilars industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.T...

$ 2,800.00

Read More
Total 61 records.